Seeing Is Believing
CRSP is currently covered by 17 analysts with an average price target of $63.79. This is a potential upside of $22.2 (53.38%) from yesterday's end of day stock price of $41.59.
Crispr Therapeutics AG's activity chart (see below) currently has 207 price targets and 196 ratings on display. The stock rating distribution of CRSP is 65.28% BUY, 26.39% HOLD and 8.33% SELL.
Analysts average stock forecasts to be materialized ratio is 64.2% with an average time for these price targets to be met of 99.46 days.
Highest price target for CRSP is $105, Lowest price target is $48, average price target is $63.79.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 14-Jan-2025. First documented stock forecast 15-Nov-2016.
Currently out of the existing stock ratings of CRSP, 47 are a BUY (65.28%), 19 are a HOLD (26.39%), 6 are a SELL (8.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$84
$42.41 (101.97%)
$84
18 days ago
(14-Jan-2025)
8/17 (47.06%)
$45.64 (118.98%)
214
Buy
$86
$44.41 (106.78%)
$86
1 months 12 days ago
(20-Dec-2024)
10/13 (76.92%)
$45.61 (112.92%)
170
Buy
$94
$52.41 (126.02%)
$94
1 months 22 days ago
(10-Dec-2024)
3/12 (25%)
$44.53 (90.01%)
27
Hold
$55
$13.41 (32.24%)
$59
2 months 26 days ago
(06-Nov-2024)
10/15 (66.67%)
$4.81 (9.58%)
101
Hold
$53
$11.41 (27.43%)
$53
2 months 26 days ago
(06-Nov-2024)
9/11 (81.82%)
$2.81 (5.60%)
180
What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?
Which analyst has the current highest performing score on CRSP (Crispr Therapeutics AG) with a proven track record?
Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?